NM_003183.6:c.1345-1597T>G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_003183.6(ADAM17):​c.1345-1597T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.23 in 151,950 control chromosomes in the GnomAD database, including 4,761 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.23 ( 4760 hom., cov: 31)
Exomes 𝑓: 0.31 ( 1 hom. )

Consequence

ADAM17
NM_003183.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.257

Publications

15 publications found
Variant links:
Genes affected
ADAM17 (HGNC:195): (ADAM metallopeptidase domain 17) This gene encodes a member of the ADAM (a disintegrin and metalloprotease domain) family. Members of this family are membrane-anchored proteins structurally related to snake venom disintegrins, and have been implicated in a variety of biologic processes involving cell-cell and cell-matrix interactions, including fertilization, muscle development, and neurogenesis. The encoded preproprotein is proteolytically processed to generate the mature protease. The encoded protease functions in the ectodomain shedding of tumor necrosis factor-alpha, in which soluble tumor necrosis factor-alpha is released from the membrane-bound precursor. This protease also functions in the processing of numerous other substrates, including cell adhesion proteins, cytokine and growth factor receptors and epidermal growth factor (EGF) receptor ligands, and plays a prominent role in the activation of the Notch signaling pathway. Elevated expression of this gene has been observed in specific cell types derived from psoriasis, rheumatoid arthritis, multiple sclerosis and Crohn's disease patients, suggesting that the encoded protein may play a role in autoimmune disease. Additionally, this protease may play a role in viral infection through its cleavage of ACE2, the cellular receptor for SARS-CoV and SARS-CoV-2. [provided by RefSeq, Aug 2020]
IAH1 (HGNC:27696): (isoamyl acetate hydrolyzing esterase 1 (putative)) Enables identical protein binding activity. Predicted to be involved in lipid catabolic process. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.306 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ADAM17NM_003183.6 linkc.1345-1597T>G intron_variant Intron 11 of 18 ENST00000310823.8 NP_003174.3 P78536-1B2RNB2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ADAM17ENST00000310823.8 linkc.1345-1597T>G intron_variant Intron 11 of 18 1 NM_003183.6 ENSP00000309968.3 P78536-1

Frequencies

GnomAD3 genomes
AF:
0.230
AC:
34880
AN:
151816
Hom.:
4764
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.111
Gnomad AMI
AF:
0.288
Gnomad AMR
AF:
0.197
Gnomad ASJ
AF:
0.312
Gnomad EAS
AF:
0.00503
Gnomad SAS
AF:
0.249
Gnomad FIN
AF:
0.286
Gnomad MID
AF:
0.316
Gnomad NFE
AF:
0.310
Gnomad OTH
AF:
0.267
GnomAD4 exome
AF:
0.313
AC:
5
AN:
16
Hom.:
1
Cov.:
0
AF XY:
0.357
AC XY:
5
AN XY:
14
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
4
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.417
AC:
5
AN:
12
Other (OTH)
AC:
0
AN:
0
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.230
AC:
34879
AN:
151934
Hom.:
4760
Cov.:
31
AF XY:
0.226
AC XY:
16766
AN XY:
74278
show subpopulations
African (AFR)
AF:
0.111
AC:
4586
AN:
41458
American (AMR)
AF:
0.197
AC:
3004
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.312
AC:
1084
AN:
3472
East Asian (EAS)
AF:
0.00504
AC:
26
AN:
5158
South Asian (SAS)
AF:
0.248
AC:
1192
AN:
4816
European-Finnish (FIN)
AF:
0.286
AC:
3018
AN:
10536
Middle Eastern (MID)
AF:
0.313
AC:
90
AN:
288
European-Non Finnish (NFE)
AF:
0.310
AC:
21057
AN:
67928
Other (OTH)
AF:
0.266
AC:
560
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1305
2611
3916
5222
6527
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
370
740
1110
1480
1850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.278
Hom.:
19857
Bravo
AF:
0.213
Asia WGS
AF:
0.112
AC:
388
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
4.7
DANN
Benign
0.68
PhyloP100
0.26
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1056204; hg19: chr2-9647091; API